Robeco Institutional Asset Management B.V. Buys 9,256 Shares of Molina Healthcare, Inc $MOH

Key Points

• Robeco Institutional Asset Management acquired 9,256 Molina Healthcare shares worth approximately $1.75 million, while institutional investors and hedge funds collectively own 98.5% of the stock.
• Molina beat quarterly expectations with EPS of $0.89 versus $0.79 expected and revenue of $11.08 billion versus $10.86 billion expected. However, revenue fell 3.4% year over year, EPS declined from $1.84, and net income dropped sharply.
• Analyst sentiment remains mixed, with a consensus “Hold” rating and a $209.62 price target near the stock’s $208.96 price. Membership declines, elevated medical costs and Medicaid-rate uncertainty remain key risks.

Robeco Institutional Asset Management B.V. bought a new stake in Molina Healthcare, Inc (NYSE:MOH - Free Report) during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm bought 9,256 shares of the company's stock, valued at approximately $1,750,000.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. BlackRock Inc. acquired a new position in shares of Molina Healthcare in the 2nd quarter valued at $1,503,052,000. Wellington Management Group LLP boosted its stake in shares of Molina Healthcare by 11.9% during the second quarter. Wellington Management Group LLP now owns 1,267,207 shares of the company's stock worth $289,810,000 after buying an additional 135,247 shares during the period. Dimensional Fund Advisors LP boosted its stake in shares of Molina Healthcare by 23.7% during the first quarter. Dimensional Fund Advisors LP now owns 1,394,882 shares of the company's stock worth $185,929,000 after buying an additional 267,121 shares during the period. Manning & Napier Advisors LLC acquired a new stake in shares of Molina Healthcare during the second quarter worth about $152,339,000. Finally, Bank of New York Mellon Corp purchased a new position in shares of Molina Healthcare during the second quarter worth about $86,138,000. 98.50% of the stock is owned by institutional investors and hedge funds.

Molina Healthcare Trading Down 0.1%

Shares of Molina Healthcare stock opened at $208.96 on Monday. The firm has a market cap of $10.91 billion, a price-to-earnings ratio of -217.66, a price-to-earnings-growth ratio of 29.89 and a beta of 0.78. Molina Healthcare, Inc has a 52-week low of $121.06 and a 52-week high of $244.89. The company's 50-day simple moving average is $200.65 and its 200-day simple moving average is $196.52. The company has a quick ratio of 1.69, a current ratio of 1.69 and a debt-to-equity ratio of 0.95.

Molina Healthcare (NYSE:MOH - Get Free Report) last announced its quarterly earnings data on Wednesday, October 21st. The company reported $0.89 earnings per share for the quarter, beating analysts' consensus estimates of $0.79 by $0.10. Molina Healthcare had a positive return on equity of 2.50% and a negative net margin of 0.11%. The company had revenue of $11.08 billion for the quarter, compared to analyst estimates of $10.86 billion. During the same quarter in the previous year, the company earned $1.84 EPS. The firm's revenue for the quarter was down 3.4% compared to the same quarter last year. As a group, equities research analysts anticipate that Molina Healthcare, Inc will post 5.30 earnings per share for the current year.

Key Molina Healthcare News

Here are the key news stories impacting Molina Healthcare this week:

• Positive Sentiment: Third-quarter adjusted EPS came in at $0.89, ahead of estimates, while revenue of $11.08 billion also exceeded expectations. The company reaffirmed its broader outlook, supporting confidence that Medicaid margins are stabilizing. Molina Surpasses Q3 Earnings and Revenue Estimates
• Positive Sentiment: Management outlined at least $45 billion of premium revenue for 2027, while its earnings “building blocks” totaled more than $9.50 per share. The outlook suggests potential for growth from premium expansion, Medicaid rate increases and improved margins. Molina Outlines 2027 Premium and EPS Outlook
• Positive Sentiment: Bank of America Securities maintained a Buy rating on MOH, indicating that some analysts view the recent weakness as an opportunity despite near-term cost pressures. Bank of America Maintains Buy Rating
• Neutral Sentiment: Molina updated fiscal 2026 EPS guidance to approximately $5.25, broadly in line with the $5.26 consensus estimate. The limited change reduces the likelihood of a major earnings-estimate reset but offers little new upside catalyst.
• Neutral Sentiment: Analyst opinion remains divided: Morgan Stanley raised its price target from $167 to $192 but retained an Equal Weight rating, while other coverage remains more constructive. Morgan Stanley Raises Molina Price Target
• Negative Sentiment: Net income fell sharply year over year to about $38 million, and revenue declined 3.4% from the prior-year quarter. Earnings also dropped from $1.84 per share a year earlier, highlighting continued profitability pressure despite the quarterly beat. Molina Reports Q3 Net Income Decline
• Negative Sentiment: Membership shrinkage, elevated medical costs and uncertainty around Medicaid rate timing remain key risks. Morgan Stanley’s target is below the current trading level, reinforcing valuation concerns and helping explain the pressure on MOH shares.

Analyst Upgrades and Downgrades

Several equities analysts recently issued reports on MOH shares. Weiss Ratings upgraded Molina Healthcare from a "sell (d)" rating to a "sell (d+)" rating in a research report on Wednesday. Cantor Fitzgerald reaffirmed a "neutral" rating on shares of Molina Healthcare in a research note on Friday, October 9th. Morgan Stanley lifted their target price on Molina Healthcare from $167.00 to $192.00 and gave the company an "equal weight" rating in a research note on Friday. Sanford C. Bernstein set a $286.00 target price on Molina Healthcare in a report on Monday, July 13th. Finally, Robert W. Baird set a $198.00 target price on Molina Healthcare in a report on Friday. Three research analysts have rated the stock with a Buy rating, thirteen have assigned a Hold rating and two have given a Sell rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of "Hold" and a consensus price target of $209.62.

About Molina Healthcare

Molina Healthcare, Inc is a managed-care company that provides health insurance and related services primarily through government-sponsored programs. Its offerings include Medicaid, Medicare, Medicare-Medicaid dual-eligible plans and health plans sold through government marketplaces under the Affordable Care Act.

The company's services generally include medical care coordination, behavioral health support, pharmacy benefits and, depending on the plan and state, dental and vision benefits.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.